Home › NPS Pharmaceuticals Receives Orphan Drug Designation for Natpara in Europe
 

Keywords :   


NPS Pharmaceuticals Receives Orphan Drug Designation for Natpara in Europe

2014-01-04 07:51:40| Biotech - Topix.net

NPS Pharmaceuticals, Inc. , a global biopharmaceutical company pioneering and delivering therapies that transform the lives of patients with rare diseases, today announced that the European Commission has granted orphan drug designation to Natpara for the treatment of hypoparathyroidism.

Tags: europe drug receives designation

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
07.10Hurricane Milton Potential Storm Surge Flooding Map
07.10Hurricane Milton Probabilistic Storm Surge Graphics
07.10Hurricane Milton Graphics
07.10Hurricane Leslie Forecast Discussion Number 19
07.10Hurricane Milton Forecast Discussion Number 7
07.10Hurricane Milton Wind Speed Probabilities Number 7
07.10Hurricane Leslie Graphics
07.10Hurricane Milton Forecast Advisory Number 7
More »